Dallas, TX, December 13, 2012 --(PR.com
)-- BioLife Cell Bank, a licensee of the proprietary adipose (fat) tissue cryogenic storage system from Cytori Therapeutics (Nasdaq: CYTX), has stored more than 1,000 individual samples--accepting a transfer of adipose-derived stem cell samples. Clyde Shores, executive vice president of Cytori, congratulates BioLife on reaching this important milestone.
Before, during and after successful transfer to BioLife in Dallas, cells were kept in a suspended state of cryopreservation utilizing liquid nitrogen within special canisters and shippers (dewars). Some of the samples have already been cryopreserved for nearly a decade.
“BioLife is dedicated to tissue banking--specifically, human fat and the stem cells that reside within it,” said Mindy Du, BioLife laboratory and research director. “Usually, we are the ones who process and preserve it, so it was a new experience to receive tissue that has already been cryopreserved. The Cytori and BioLife teams worked together and executed the transfer seamlessly.”
"I’d like to thank Cytori for their continued support, enthusiasm and direction as BioLife continues to grow," said John A. Carbona, chief executive officer of BioLife. "We feel honored that Cytori and dozens of patients are entrusting our company with the care of these samples.”
Founded by Dr. David Genecov and John D. Harkey Jr., BioLife is a leader in cryogenic storage of adipose (fat) tissue and adult mesenchymal stem and regenerative cells. Tissue is removed via liposuction and may be cryogenically preserved for use in future medical procedures.
More than 150 doctors utilize BioLife services. Physician referrals are available by contacting BioLife (972-331-1905) or by visiting biolifecellbank.com.
As part of their core business, BioLife Cell Bank, Inc. offers individuals a way to safely store their adipose (fat) tissue and/or their adipose-derived stem and regenerative cells--giving patients and physicians easy, multi-use access to cells and tissue for future cosmetic, reconstructive and regenerative therapies. Extracted via liposuction, tissue is sent to BioLife in a collection kit (validated to E.T.L. standards) where it is processed using proprietary technology and Cytori Therapeutics' products. Tissue is cryogenically preserved, and may be stored indefinitely. BioLife is registered with the FDA as a processing bank and complies with FDA regulations and guidance including current Good Tissue Practice (cGTP). BioLife is based in Dallas, Texas, at Forest Park Medical Center. For more information: biolifecellbank.com.
John A. Carbona, 972-331-1905
Chief Executive Officer
Kristin Laminack, 972-331-9626
Director, Marketing and Media